Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04199104
Brief Title: A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010) (LEAP-10)

First Submitted : December 12, 2019
First Submitted that Met QC Criteria : December 12, 2019
First Posted : December 13, 2019

Last Update Submitted that Met QC Criteria : September 12, 2021
Last Update Posted : September 14, 2021